Narrative review / 2012
A commentary reports that 60 g/day of strawberry powder reduced the histologic grade of dysplastic lesions in an esophageal cancer prevention trial.
This commentary discusses a randomized noncomparative phase II trial in China testing two doses of strawberry powder (60 g/d or 30 g/d for six months) to prevent esophageal cancer. The 60 g/d dose reduced the histologic grade of dysplastic lesions and reduced localized biomarkers, whereas the 30 g/d dose was not effective. The author notes that fundamental questions remain regarding formulation, active components, and mechanisms of action.
- Study type
- Editorial / commentary on a randomized phase II trial
- Who was studied
- Individuals in China evaluated for esophageal cancer prevention
- What was measured
- Histologic grade of dysplastic lesions and localized biomarkers
THE PAPER
Strawberry fields forever?
Suh N, Pezzuto JM. Cancer Prev Res (Phila), 2012.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.